Innovators from Global Biopharma Companies Discuss Consumer & Physician E-marketing Trends

Manhattan ResearchIn recent years European healthcare consumers and physicians have steadily increased their use of the Internet for treatment and product decisions. According to healthcare and pharmaceutical market research company's Manhattan Research's Cybercitizen Health™ Europe v8.0 study and strategy advisory service, over 150 million adults in countries across Europe used online channels to access health information in 2008.

In light of these trends, it's become necessary for biopharmaceutical companies to explore digital strategies in order to connect with target consumer and physician audiences at both a European and global level - however, they face a myriad of challenges in terms of regulations, process, and internal understanding.

To encourage innovation and knowledge-sharing across the industry, Manhattan Research releases its 2008 European Opinion Leader Roundtable report - a collection of opinions and best practices on key e-marketing and sales topics from innovators at AstraZeneca, UCB Pharma, Shire Pharmaceuticals, and Across Health. The virtual discussion is led by Manhattan Research President Mark Bard.

"Biopharma companies in Europe - and globally as well - can no longer afford to ignore 'e' channels as viable and cost-effective ways to reach consumer and physician groups," said Mr. Bard, "The key opinion leaders in this roundtable are catalysts for digital innovation within their respective organizations and offer valuable lessons learned and best practices for marketing and sales teams."

European Opinion Leader Roundtable Summary

Moderator:
Mark Bard, Manhattan Research

Opinion Leaders:
John Fish, AstraZeneca
Jean-Pierre Henskens, UCB Pharma
Gene Miller, Shire Pharmaceuticals
Fonny Schenck, Across Health

Topics:

  • Web-Empowered Healthcare Consumers
  • Facing Regulatory Challenges
  • Patient Compliance & Digital Strategy
  • Search Engine Marketing
  • Physicians & Closed Loop Marketing
  • Integration & Measurement
  • E-marketing Lessons Learned

The roundtable report is available to download on the Manhattan Research website. Please visit: http://www.manhattanresearch.com/research/roundtables/european-roundtable-2008.aspx.

Manhattan Research European Study & Strategic Advisory Service Products
Manhattan Research offers two European market research study & strategic advisory services for the healthcare and biopharmaceutical companies.

Cybercitizen Health™ Europe is focused on how European consumers use new media and technology for health information and its impact on treatment and product decisions. The latest study was conducted in Q3 2008 among 4,079 consumers in the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. Cybercitizen Health™ Europe identifies and analyses the behaviour, attitudes, and demographics of the consumer population who use technology and the Internet for health purposes, as well as further segmenting the population by therapeutic area, technology utilisation, and motivation. For more information, visit http://www.manhattanresearch.com/products/consumer/ccheu.aspx

Taking the Pulse® Europe is focused on how physicians across Europe use new media and technology for professional purposes. The next study will be available at the end of Q4 2008. Last year's study was fielded among 1,000 physicians from the United Kingdom, Germany, Spain, Italy, and France. Taking the Pulse® Europe provides pharmaceutical and healthcare companies with key data and insight about the evolving nature of physician channel mix, media and technology usage, and healthcare information with the goal of helping companies understand how physicians across Europe access health information. For more information, visit http://www.manhattanresearch.com/products/physician/EUphysicians.aspx

In addition to the core data, subscribing clients have access to the Manhattan Research analyst team and the ability to request country-specific therapeutic and specialist segmentations.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

Most Popular Now

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

A soybean protein blocks LDL cholesterol productio…

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study...

Discovery of anti-cancer chemistry makes skullcap …

The evolutionary secrets that enable the medicinal herb known as barbed skullcap to produce cancer fighting compounds have been unlocked by a collaboration of UK and Chin...